Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma

Clinical trial NCT04042805 · UNKNOWN

Trial details

NCT number: NCT04042805
Sponsor: Baocai Xing
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-08-01
Primary completion: 2022-08-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.